Barclays Issues Pessimistic Forecast for HCA Healthcare (NYSE:HCA) Stock Price

HCA Healthcare (NYSE:HCA) had its price objective dropped by analysts at Barclays from $427.00 to $402.00 in a report issued on Thursday, MarketBeat Ratings reports. The brokerage presently has an “equal weight” rating on the stock. Barclays‘s price objective indicates a potential upside of 8.18% from the stock’s previous close.

HCA has been the topic of several other reports. Raymond James Financial set a $528.00 target price on shares of HCA Healthcare in a research report on Tuesday, July 7th. Robert W. Baird reduced their target price on HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating for the company in a report on Wednesday, April 15th. Cantor Fitzgerald reduced their price objective on shares of HCA Healthcare from $588.00 to $525.00 and set an “overweight” rating for the company in a research note on Tuesday, July 7th. TD Cowen dropped their target price on shares of HCA Healthcare from $500.00 to $431.00 and set a “buy” rating on the stock in a report on Monday, June 22nd. Finally, Sanford C. Bernstein reaffirmed a “market perform” rating on shares of HCA Healthcare in a research report on Wednesday. Fourteen investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $486.14.

HCA Healthcare Trading Down 3.7%

HCA opened at $371.60 on Thursday. HCA Healthcare has a 1 year low of $330.00 and a 1 year high of $556.52. The stock has a fifty day moving average price of $392.25 and a 200 day moving average price of $457.05. The stock has a market cap of $82.44 billion, a price-to-earnings ratio of 12.78, a PEG ratio of 1.27 and a beta of 1.12.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.19 by ($0.04). The firm had revenue of $19.11 billion for the quarter, compared to analyst estimates of $19.09 billion. HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The firm’s quarterly revenue was up 4.3% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $6.45 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, sell-side analysts forecast that HCA Healthcare will post 29.74 earnings per share for the current fiscal year.

Institutional Trading of HCA Healthcare

A number of institutional investors and hedge funds have recently modified their holdings of HCA. Brighton Jones LLC bought a new position in shares of HCA Healthcare in the fourth quarter valued at about $1,021,000. NewEdge Advisors LLC lifted its position in shares of HCA Healthcare by 11.9% during the first quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock worth $1,334,000 after purchasing an additional 409 shares in the last quarter. Sivia Capital Partners LLC raised its position in HCA Healthcare by 5.5% in the 2nd quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock worth $241,000 after purchasing an additional 33 shares during the last quarter. Jump Financial LLC bought a new stake in shares of HCA Healthcare during the second quarter worth $2,073,000. Finally, Sei Investments Co. boosted its stake in shares of HCA Healthcare by 56.3% in the 2nd quarter. Sei Investments Co. now owns 136,589 shares of the company’s stock valued at $52,328,000 after purchasing an additional 49,214 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.